stockrowAurora Cannabis Inc. (ACB) vs Emergent Biosolutions Inc. (EBS)
- Aurora Cannabis Inc. ACB 5.23 +0.77%
- Emergent Biosolutions Inc. EBS 6.01 +2.74%
Aurora Cannabis Inc. and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $341.2M against $300.8M — 1.1× the size. Emergent Biosolutions Inc. grew revenue faster over the last twelve months: −17.7% against −18.2%. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −40.2%) and the higher return on invested capital (−5.58% vs −17.5%). Across the 19 metrics below, Aurora Cannabis Inc. leads on 12 and Emergent Biosolutions Inc. on 7.
Valuation
Profitability
| Metric | ACB | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.74% | 48.42% | 53.51% |
| Operating margin | (12.13%) | (27.70%) | 0.00% |
| Net margin | (38.12%) | (40.16%) | (2.45%) |
| Free cash flow margin | (17.19%) | 29.89% | 0.00% |
| Return on equity | (19.85%) | (58.21%) | (0.80%) |
| Return on assets | (15.19%) | (21.23%) | (1.67%) |
| Return on invested capital | (5.58%) | (17.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack